![January 2024: Transitional community adherence support for people leaving incarceration in South Africa — a pragmatic, open-label, randomized controlled trial](https://icap.columbia.edu/wp-content/uploads/JC-2.jpg)
HIV care and treatment
![January 2024: Transitional community adherence support for people leaving incarceration in South Africa — a pragmatic, open-label, randomized controlled trial](https://icap.columbia.edu/wp-content/uploads/JC-2.jpg)
![July/August 2023: Second-Line Switch to Dolutegravir for Treatment of HIV Infection](https://icap.columbia.edu/wp-content/uploads/JC_July_Aug-2023-Photo-1080x675.jpg)
July/August 2023: Second-Line Switch to Dolutegravir for Treatment of HIV Infection
Article and Study Summary: Second-Line Switch to Dolutegravir for Treatment of HIV Infection Published in: N Engl J Med. 2023;388(25):2349-2359 https://www.nejm.org/doi/full/10.1056/NEJMoa2210005 Authors: Ombajo LA, Penner J, Nkuranga J, et al. Summary The...![May/June 2023: Adaptive Strategies for Retention in Care among Persons Living with HIV](https://icap.columbia.edu/wp-content/uploads/Journal-Club-May_June-2023_final-1080x675.jpg)
May/June 2023: Adaptive Strategies for Retention in Care among Persons Living with HIV
Article and Study Summary: Adaptive Strategies for Retention in Care among Persons Living with HIV Published in: NEJM Evid 2023;2(4) https://evidence.nejm.org/doi/full/10.1056/EVIDoa2200076 Authors: Geng EH, Odeny TA, Montoya LM, et al. Summary This trial used a...Integrating isoniazid preventive therapy into the fast-track HIV treatment model in urban Zambia: A proof-of-concept pilot project
Authors: Mpande Mukumbwa-Mwenechanya, Muhau Mubiana, Paul Somwe, Khozya Zyambo, Maureen Simwenda, Nancy Zongwe, Estella Kalunkumya, Linah Kampilimba Mwango, Miriam Rabkin, Felton Mpesela, Fred Chungu, Felix Mwanza, Peter Preko, Carolyn Bolton-Moore, Samuel Bosomprah,...![February 2022: Dolutegravir as First- or Second-line Treatment for HIV-1 Infection in Children](https://icap.columbia.edu/wp-content/uploads/istock1-1080x675.png)